All stock lists
argenx SE (NASDAQ:ARGX)
NL · Delayed Price · Currency is USD
Healthcare · Biotechnology
$964.41-$16.91 (-1.72%)
Market cap
$59.9B
Insider Score
Health Score
Analyst consensus
Listed since
May 18, 2017
Website
Insider Score
––Not scored
ARGX Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Congress Trading
Recent trades of ARGX by members of U.S. Congress
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 27, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 15, 2026 |
| Gilbert CisnerosHouse / D | Purchase$15.00K – $50.00K | Oct 14, 2026 |
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 30, 2026 |
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
ARGX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ARGX patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ARGX from public contracts
Source: USAspending.gov
Recently reported changes in ARGX holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing ARGX, reported under the STOCK Act.
Filters
| House | Buy | $1.00K – $15.00K | Oct 27, 2026 | |
| House | Buy | $1.00K – $15.00K | Oct 15, 2026 | |
| House | Buy | $15.00K – $50.00K | Oct 14, 2026 | |
| Senate | Buy | $1.00K – $15.00K | Mar 30, 2026 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.